AUD209.34
2.19% yesterday
Australia, Nov 15, 06:00 am CET
ISIN
AU000000PME8
Symbol
PME

Pro Medicus Target price 2024 - Analyst rating & recommendation

Pro Medicus Classifications & Recommendation:

Buy
14%
Hold
71%
Sell
14%

Pro Medicus Price Target

Target Price AUD153.15
Price AUD209.86
Deviation
Number of Estimates 13
13 Analysts have issued a price target Pro Medicus 2025 . The average Pro Medicus target price is AUD153.15. This is lower than the current stock price. The highest price target is , the lowest is
AUD100.00 52.35%
register free of charge
.
A rating was issued by 14 analysts: 2 Analysts recommend Pro Medicus to buy, 10 to hold and 2 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Pro Medicus stock has an average upside potential 2025 of . Most analysts recommend the Pro Medicus stock at Hold.

Sales and Margin forecast 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Jun '24 2025
Estimates
Revenue Million AUD 161.50 210.26
29.30% 30.19%
EBITDA Margin 74.77% 75.93%
1.73% 1.55%
Net Margin 51.08% 52.47%
5.34% 2.72%

12 Analysts have issued a sales forecast Pro Medicus 2025 . The average Pro Medicus sales estimate is

AUD210m
Unlock
. This is
30.19% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
AUD218m 35.23%
Unlock
, the lowest is
AUD203m 25.70%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 AUD162m 29.30%
2025
AUD210m 30.19%
Unlock
2026
AUD262m 24.76%
Unlock
2027
AUD324m 23.60%
Unlock
2028
AUD388m 19.76%
Unlock

13 Analysts have issued an Pro Medicus EBITDA forecast 2025. The average Pro Medicus EBITDA estimate is

AUD160m
Unlock
. This is
32.21% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
AUD173m 43.34%
Unlock
, the lowest is
AUD152m 26.04%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 AUD121m 31.55%
2025
AUD160m 32.21%
Unlock
2026
AUD202m 26.36%
Unlock
2027
AUD253m 25.19%
Unlock
2028
AUD323m 27.98%
Unlock

EBITDA Margin

2024 74.77% 1.73%
2025
75.93% 1.55%
Unlock
2026
76.91% 1.29%
Unlock
2027
77.90% 1.29%
Unlock
2028
83.24% 6.85%
Unlock

6 Pro Medicus Analysts have issued a net profit forecast 2025. The average Pro Medicus net profit estimate is

AUD110m
Unlock
. This is
33.75% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
AUD118m 43.29%
Unlock
, the lowest is
AUD102m 23.67%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 AUD82.5m 36.21%
2025
AUD110m 33.75%
Unlock
2026
AUD143m 29.97%
Unlock
2027
AUD184m 28.39%
Unlock
2028
AUD235m 27.78%
Unlock

Net Margin

2024 51.08% 5.34%
2025
52.47% 2.72%
Unlock
2026
54.67% 4.19%
Unlock
2027
56.79% 3.88%
Unlock
2028
60.59% 6.69%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Jun '24 2025
Estimates
Earnings Per Share AUD 0.79 1.06
36.21% 34.18%
P/E 198.63
EV/Sales 103.57

6 Analysts have issued a Pro Medicus forecast for earnings per share. The average Pro Medicus <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

AUD1.06
Unlock
. This is
34.18% higher
Unlock
than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
AUD1.13 43.04%
Unlock
, the lowest is
AUD0.98 24.05%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 AUD0.79 36.21%
2025
AUD1.06 34.18%
Unlock
2026
AUD1.37 29.25%
Unlock
2027
AUD1.76 28.47%
Unlock
2028
AUD2.25 27.84%
Unlock

P/E ratio

Current 264.71 80.59%
2025
198.63 24.96%
Unlock
2026
152.81 23.07%
Unlock
2027
119.02 22.11%
Unlock
2028
93.15 21.74%
Unlock

Based on analysts' sales estimates for 2025, the Pro Medicus stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

103.57
Unlock
and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of
104.30
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 134.84 91.86%
2025
103.57 23.19%
Unlock
2026
83.02 19.85%
Unlock
2027
67.17 19.10%
Unlock
2028
56.08 16.50%
Unlock

P/S ratio

Current 135.79 90.62%
2025
104.30 23.19%
Unlock
2026
83.60 19.85%
Unlock
2027
67.64 19.10%
Unlock
2028
56.48 16.50%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today